Hypoglycemia and diabetes: increased need for awareness

References

• Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: US Department of Health and Human Services, 2014
   Google Scholar
• Unger J. Diagnosis and management in T2DM. In: Schwartz Z (ed.) Diabetes Management in Primary Care, 2nd edn. Philadelphia, PA: Wolters Kluwer Health, 2013:323-412
   Google Scholar
• Stark Casagrande S, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care 2013;36:2271-9
   PubMed Web of Science ®Google Scholar
• Peyrot M, Barnett AH, Meneghini LF, Schumm-Draeger PM. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med 2012;29:682-9
   PubMed Web of Science ®Google Scholar
• Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 2013;36:1384-95
   PubMed Web of Science ®Google Scholar
• UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7
   PubMed Web of Science ®Google Scholar
• Leese GP, Wang J, Broomhall J, et al.; DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 2003;26:1176-80
   PubMed Web of Science ®Google Scholar
• Perlmuter LC, Flanagan BP, Shah PH, Singh SP. Glycemic control and hypoglycemia: is the loser the winner? Diabetes Care 2008;31:2072-6
   PubMed Web of Science ®Google Scholar
• Lipska KJ, Ross JS, Wang Y, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 2014;174:1116-24
   PubMed Web of Science ®Google Scholar
• Khunti K, Alsifri S, Aronson R, et al. Self-reported hypoglycaemia: a global study of 24 countries with 27,585 insulin-treated patients with diabetes: the HAT study. Diabetologia 2014;57(Suppl 1):Abstract 481
   Google Scholar
• Shaefer C, Dex T, Johnstone B, et al. Popularity of sulfonylureas (SU) in real-world practice: perspectives from Diabetes FORWARD (DF) (Abstract 1089-P). Diabetes 2014;63(Suppl 1):A283
   Google Scholar
• Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A. Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey. Expert Rev Pharmacoecon Outcomes Res 2013;13:123-30
   PubMed Web of Science ®Google Scholar
• McCoy RG, Van Houten HK, Ziegenfuss JY, et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 2012;35:1897-901
   PubMed Web of Science ®Google Scholar
• Hsu PF, Sung SH, Cheng HM, et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study. Diabetes Care 2013;36:894-900
   PubMed Web of Science ®Google Scholar
• Pilotto A, Noale M, Maggi S, et al. Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients. Biomed Res Int 2014:906103
   PubMedGoogle Scholar
• Lee SM, Koh D, Chui WK, Sum CF. Diabetes management and hypoglycemia in safety sensitive jobs. Saf Health Work 2011;2:9-16
   PubMedGoogle Scholar
• Signorovitch JE, Macaulay D, Diener M, et al. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab 2013;15:335-41
   PubMed Web of Science ®Google Scholar
• Berlie HD, Garwood CL. Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly. Ann Pharmacother 2010;44:712-7
   PubMed Web of Science ®Google Scholar
• Alvarez Guisasola F, Tofé Povedano S, Krishnarajah G, et al. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab 2008;10(Suppl 1):25-32
   PubMed Web of Science ®Google Scholar
• Kalra S, Mukherjee JJ, Venkataraman S, et al. Hypoglycemia: the neglected complication. Indian J Endocrinol Metab 2013;17:819-34
   PubMedGoogle Scholar
• Chow E, Bernjak A, Williams S, Fawdry RA. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 2014;63:1738-47
   PubMed Web of Science ®Google Scholar
• Dalsgaard-Nielsen J, Madsbad S, Hilsted J. Changes in platelet function, blood coagulation and fibrinolysis during insulin-induced hypoglycaemia in juvenile diabetics and normal subjects. Thromb Haemost 1982;47:254-8
   PubMed Web of Science ®Google Scholar
• Joy NG, Tate DB, Younk LM, Davis SN. Effects of acute and antecedent hypoglycemia on endothelial function and markers of atherothrombotic balance in healthy humans. Diabetes 2015;64:2571-80
   PubMed Web of Science ®Google Scholar
• Foos V, Varol N, Curtis BH, Boye KS. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States. J Med Econ 2015;18:420-32
   PubMed Web of Science ®Google Scholar
• McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabet Med 2001;18:690-705
   PubMed Web of Science ®Google Scholar
• Alsahli M, Gerich JE. Hypoglycemia. Endocrinol Metab Clin North Am 2013;42:657-76
   PubMed Web of Science ®Google Scholar
• Jaworski N, Brambrink A. Electrolyte and metabolic derangements. In: Bhardwaj A, Mirski MA (eds.) Handbook of Neurocritical Care, 2nd edn. New York, NY: Springer, 2001:13-36
   Google Scholar
• Dendy JA, Chockalingam V, Tirumalasetty NN, et al. Identifying risk factors for severe hypoglycemia in hospitalized patients with diabetes. Endocr Pract 2014;20:1051-6
   PubMed Web of Science ®Google Scholar
• Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 1988;37:901-7
   PubMed Web of Science ®Google Scholar
• Dagogo-Jack SE, Craft S, Cryer PE. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest 1993;91:819-28
   PubMed Web of Science ®Google Scholar
• Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 2008;25:245-54
   PubMed Web of Science ®Google Scholar
• Boyle PJ, Schwartz NS, Shah SD, et al. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. N Engl J Med 1988;318:1487-92
   PubMed Web of Science ®Google Scholar
• Lin YY, Hsu CW, Sheu WH, et al. Risk factors for recurrent hypoglycemia in hospitalized diabetic patients admitted for severe hypoglycemia. Yonsei Med J 2010;51:367-74
   PubMed Web of Science ®Google Scholar
• Katon WJ, Young BA, Russo J, et al. Association of depression with increased risk of severe hypoglycemic episodes in patients with diabetes. Ann Fam Med 2013;11:245-50
   PubMed Web of Science ®Google Scholar
• Farrokhi F, Klindukhova O, Chandra P, et al. Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes. J Diabetes Sci Technol 2012;6:1022-9
   PubMedGoogle Scholar
• Shafiee G, Mohajeri-Tehrani M, Pajouhi M, Larijani B. The importance of hypoglycemia in diabetic patients. J Diabetes Metab Disord 2012;11:17
   PubMedGoogle Scholar
• Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010;33:1389-94
   PubMed Web of Science ®Google Scholar
• Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes 2008;57:3169-76
   PubMed Web of Science ®Google Scholar
• Alagiakrishnan K, Mereu L. Approach to managing hypoglycemia in elderly patients with diabetes. Postgrad Med 2010;122:129-37
   PubMed Web of Science ®Google Scholar
• Fu H, Xie W, Curtis B, Schuster D. Identifying factors associated with hypoglycemia-related hospitalizations among elderly patients with T2DM in the US: a novel approach using influential variable analysis. Curr Med Res Opin 2014;30:1787-93
   PubMed Web of Science ®Google Scholar
• Arinzon Z, Fidelman Z, Berner YN, Adunsky A. Infection-related hypoglycemia in institutionalized demented patients: a comparative study of diabetic and nondiabetic patients. Arch Gerontol Geriatr 2007;45:191-200
   PubMed Web of Science ®Google Scholar
• Richardson T, Weiss M, Thomas P, Kerr D. Day after the night before: influence of evening alcohol on risk of hypoglycemia in patients with type 1 diabetes. Diabetes Care 2005;28:1801-2
   PubMed Web of Science ®Google Scholar
• Moen MF, Zhan M, Hsu VD, et al. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1121-7
   PubMed Web of Science ®Google Scholar
• Moghissi E, Ismail-Beigi F, Devine RC. Hypoglycemia: minimizing its impact in type 2 diabetes. Endocr Pract 2013;19:526-35
   PubMed Web of Science ®Google Scholar
• Rodbard HW, Schnell O, Unger J, et al. Use of an automated decision support tool optimizes clinicians’ ability to interpret and appropriately respond to structured self-monitoring of blood glucose data. Diabetes Care 2012;35:693-8
   PubMed Web of Science ®Google Scholar
• Bosi E, Scavini M, Ceriello A, et al.; PRISMA Study Group. Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial. Diabetes Care 2013;36:2887-94
   PubMed Web of Science ®Google Scholar
• Bakatselos SO. Hypoglycemia unawareness. Diabetes Res Clin Pract 2011;93(Suppl 1):S92-S6
   PubMedGoogle Scholar
• Choudhary P, Geddes J, Freeman JV, et al. Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring. Diabet Med 2010;27:666-72
   PubMed Web of Science ®Google Scholar
• Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59
   PubMed Web of Science ®Google Scholar
• Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004;350:2272-9
   PubMed Web of Science ®Google Scholar
• Brod M, Christensen T, Thomsen TL, Bushnell DM. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health 2011;14:665-71
   PubMed Web of Science ®Google Scholar
• Brod M, Wolden M, Christensen T, Bushnell DM. Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization. Value Health 2013;16:1140-9
   PubMed Web of Science ®Google Scholar
• Griffin S. Insulin treatment of type 2 diabetes: considerations when converting from human insulin to insulin analogs. Ann Med 2013;45:129-40
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diabetes and employment. Diabetes Care 2009;32(Suppl 1):S80-S4
   Google Scholar
• Lekarcyk JA, Himmel L, Munshi M. Blood glucose monitoring and underlying question of hypoglycemia are both essential to preventing hypoglycemia in nursing home residents. Clin Diabetes 2013;31:28-30
   Google Scholar
• Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009;301:1565-72
   PubMed Web of Science ®Google Scholar
• Shao W, Ahmad R, Khutoryansky N, et al. Evidence supporting an association between hypoglycemic events and depression. Curr Med Res Opin 2013;29:1609-15
   PubMed Web of Science ®Google Scholar
• Voulgari C, Pagoni S, Paximadas S, Vinik AI. “Brittleness” in diabetes: easier spoken than broken. Diabetes Technol Ther 2012;14:835-48
   PubMed Web of Science ®Google Scholar
• Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, et al. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008;31:9-14
   PubMed Web of Science ®Google Scholar
• Ly TT, Gallego PH, Davis EA, Jones TW. Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes. Diabetes Care 2009;32:1802-6
   PubMed Web of Science ®Google Scholar
• Northam EA, Anderson PJ, Jacobs R, et al. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabetes Care 2001;24:1541-6
   PubMed Web of Science ®Google Scholar
• Tsalikian E, Mauras N, Beck RW, et al.; Diabetes Research In Children Network Direcnet Study Group. Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus. J Pediatr 2005;147:528-34
   PubMed Web of Science ®Google Scholar
• Hernandez JM, Moccia T, Fluckey JD, et al. Fluid snacks to help persons with type 1 diabetes avoid late onset postexercise hypoglycemia. Med Sci Sports Exerc 2000;32:904-10
   PubMed Web of Science ®Google Scholar
• Rabasa-Lhoret R, Bourque J, Ducros F, Chiasson JL. Guidelines for premeal insulin dose reduction for postprandial exercise of different intensities and durations in type 1 diabetic subjects treated intensively with a basal–bolus insulin regimen (ultralente–lispro). Diabetes Care 2001;24:625-30
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Glycemic targets. Section 6 in Standards of Medical Care in Diabetes – 2015. Diabetes Care 2015;38(Suppl 1):S33-40
   Google Scholar
• Kedia N. Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes 2011;4:337-46
   PubMedGoogle Scholar
• Engel SS, Xu L, Andryuk PJ, et al. Efficacy and tolerability of MK-0893, a glucagon receptor antagonist (GRA), in patients with type 2 diabetes (T2DM) (Abstract 0309-OR). Diabetes 2011;60(Suppl 1):A85
   Google Scholar
• Kelly RP, Abu-Raddad EJ, Tham LS, et al. Single doses of the glucagon receptor antagonist LY2409021 reduce blood glucose in healthy subjects and patients with type 2 diabetes mellitus (T2DM) (Abstract 1004-P). Diabetes 2011;60(Suppl 1):A275
   Google Scholar
• McCoy RG, Van Houten HK, Ziegenfuss JY, et al. Self-report of hypoglycemia and health-related quality of life in patients with type 1 and type 2 diabetes. Endocr Pract 2013;19:792-9
   PubMed Web of Science ®Google Scholar
• Sutton L, Chapman-Novakofski K. Hypoglycemia education needs. Qual Health Res 2011;21:1220-8
   PubMed Web of Science ®Google Scholar
• Williamson C, Glauser TA, Burton BS, et al. Health care provider management of patients with type 2 diabetes mellitus: analysis of trends in attitudes and practices. Postgrad Med 2014;126:145-60
   PubMed Web of Science ®Google Scholar
• Chehade JM, Sheikh-Ali M, Alexandraki I, et al. The effect of healthcare provider education on diabetes management of hospitalised patients. Int J Clin Pract 2010;64:917-24
   PubMed Web of Science ®Google Scholar
• Snow R, Humphrey C, Sandall J. What happens when patients know more than their doctors? Experiences of health interactions after diabetes patient education: a qualitative patient-led study. BMJ Open 2013;3:e003583
   Google Scholar
• Moisan J, Breton MC, Villeneuve J, Grégoire JP. Hypoglycemia-related emergency department visits and hypoglycemia-related hospitalizations among new users of antidiabetes treatments. Can J Diabetes 2013;37:143-9
   PubMed Web of Science ®Google Scholar
• Garber AJ, Abrahamson MJ, Barzilay JI, et al.; American Association of Clinical Endocrinologists. AACE comprehensive diabetes management algorithm 2013. Endocr Pract 2013;19:327-36
   PubMed Web of Science ®Google Scholar
• Bonds DE, Miller ME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010;340:b4909
   PubMed Web of Science ®Google Scholar
• Geller AI, Shehab N, Lovegrove MC, et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Intern Med 2014;174:678-86
   PubMed Web of Science ®Google Scholar
• Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy 2012;32:613-17
   PubMed Web of Science ®Google Scholar
• Diamant M, Van Gaal L, Guerci B, et al. Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial. Lancet Diabetes Endocrinol 2014;2:464-73
   PubMed Web of Science ®Google Scholar
• Dicembrini I, Pala L, Rotella CM. From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy. Exp Diabetes Res 2011;2011:898913
   PubMedGoogle Scholar
• Davidson JA. The placement of DPP-4 inhibitors in clinical practice recommendations for the treatment of type 2 diabetes. Endocr Pract 2013;19:1050-61
   PubMed Web of Science ®Google Scholar
• Rosenwasser RF, Sultan S, Sutton D, et al. SGLT-2 inhibitors and their potential in the treatment of diabetes. Diabetes Metab Syndr Obes 2013;6:453-67
   PubMedGoogle Scholar
• Nathan DM, Buse JB, Davidson MB, et al.; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
   PubMed Web of Science ®Google Scholar
• Khunti K, Fisher H, Paul S, et al. Severe hypoglycaemia requiring emergency medical assistance by ambulance services in the East Midlands: a retrospective study. Prim Care Diabetes 2013;7:159-65
   PubMed Web of Science ®Google Scholar
• Goldstein BJ, Mueller-Wieland D. Type 2 Diabetes: Principles and Practice, 2nd edn. Boca Raton, FL: Taylor & Francis Group, 2007
   Google Scholar
• Riddle MC, Rosenstock J, Gerich J; Insulin Glargine 4002 Study Investigators. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-6
   PubMed Web of Science ®Google Scholar
• Hermansen K, Davies M, Derezinski T, et al. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naïve people with type 2 diabetes. Diabetes Care 2006;29:1269-74 [erratum in Diabetes Care 2007;30:1035]
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-9
   PubMed Web of Science ®Google Scholar
• Sanofi. Sanofi receives FDA approval of once-daily basal insulin Toujeo. Paris, France, 26 February 2015. Available at: http://hugin.info/152918/R/1897483/673465.pdf [Last accessed April 28, 2015]
   Google Scholar
• Steinstraesser A, Schmidt R, Bergmann K, et al. Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml. Diabetes Obes Metab 2014;16:873-6
   PubMed Web of Science ®Google Scholar
• Dahmen R, Bergmann K, Lehmann A, et al. New insulin glargine U300 formulation evens and prolongs steady state PK and PD proflles during euglycemic clamp in patients with type 1 diabetes (T1DM) (Abstract 113-OR). Diabetes 2013;62(Suppl 1):A29
   Google Scholar
• Riddle MC, Bolli GB, Ziemen M, et al.; EDITION 1 Study Investigators. New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1). Diabetes Care 2014;37:2755-62
   PubMed Web of Science ®Google Scholar
• Aye MM, Atkin SL. Patient safety and minimizing risk with insulin administration – role of insulin degludec. Drug Healthc Patient Saf 2014;6:55-67
   PubMedGoogle Scholar
• Ratner RE, Gough SC, Mathieu C, et al. Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes Obes Metab 2013;15:175-84
   PubMed Web of Science ®Google Scholar
• Perfetti R. Combining basal insulin analogs with glucagon-like peptide-1 mimetics. Diabetes Technol Ther 2011;13:873-81
   PubMed Web of Science ®Google Scholar
• Berlie H, Hurren KM, Pinelli NR. Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review. Diabetes Metab Syndr Obes 2012;5:165-74
   PubMedGoogle Scholar
• Balena R, Hensley IE, Miller S, Barnett AH. Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature. Diabetes Obes Metab 2013;15:485-502
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Approaches to glycemic treatment. Section 7 in Standards of Medical Care in Diabetes – 2015. Diabetes Care 2015;38(Suppl 1):S41-8
   Google Scholar
• Simon D, de Pablos-Velasco P, Parhofer KG, et al. Hypoglycaemic episodes in patients with type 2 diabetes – risk factors and associations with patient-reported outcomes: the PANORAMA Study. Diabetes Metab 2015;41:470-9
   PubMed Web of Science ®Google Scholar
• [No authors listed.] Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial. Diabetes Care 1996;19:195-203
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995;18:754-60
   PubMed Web of Science ®Google Scholar
• Bradley C, Todd C, Gorton T, et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999;8:79-91
   PubMed Web of Science ®Google Scholar
• Cox DJ, Irvine A, Gonder-Frederick L, et al. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987;10:617-21
   PubMed Web of Science ®Google Scholar
• Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33
   PubMed Web of Science ®Google Scholar
• EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy; 1999 16:199-208
   Google Scholar
• McTavish L, Wiltshire E. Effective treatment of hypoglycemia in children with type 1 diabetes: a randomized controlled clinical trial. Pediatr Diabetes 2011;12(4 Pt 2):381-7
   PubMed Web of Science ®Google Scholar